What does s42DN-42DQ require?

Public-facing general information about what therapeutic goods contain (their ingredients or components) has to meet those parts of the Therapeutic Goods Advertising Code that the regulations apply to it, treated as though it were an advertisement. Disseminating non-compliant generic information is an offence (12 months or 1,000 penalty units, or 100 penalty units strict liability) and a civil penalty (section 42DQ).

Australia Therapeutic Goods Act 1989 s42DN-42DQ: When...

Other controls in Chapter 4A and Chapter 5: vaping goods, advertising and generic information, counterfeit goods and product tampering – Australia Therapeutic Goods Act 1989

s42DD-42DK Use a restricted representation (a reference to a serious form of a disease or condition identified in the Code) only with an approval or permission, include every required representation, use prohibited representations only with the Secretary's written permission, and keep to any conditions
s42DL-42DLC Do not advertise therapeutic goods with unapproved prohibited or restricted representations, without required representations, with references to the Act, with implied government endorsement, or referring to Schedule 3, 4 or 8 substances, biologicals or prescribed unregistered goods, and obey any notice banning a false representation
s42DM-42DMA Make every public advertisement for therapeutic goods comply with the Therapeutic Goods Advertising Code, noting each day of continuing non-compliance is a separate contravention
s42DR-42DX Answer the Secretary's advertising or generic information substantiation notices within the period set (at least 14 days) and comply with directions to cease, retract, correct, recover or destroy advertisements or stop a claim
s42E-42F Never manufacture, supply, import or export counterfeit therapeutic goods, meaning goods whose label, presentation, records or advertising falsely represent their identity, composition, ingredients, strength, size, sponsor, source, manufacturer or place of manufacture
s42T-42U Notify the Secretary within 24 hours of becoming aware of actual or potential tampering, or a substantial risk of it, with any therapeutic goods you supply, manufacture or sponsor, and within 24 hours of receiving any information or demand about tampering
s42V-42W Comply with tampering recall and public notification requirements, and do not supply or export goods of a kind or batch subject to a tampering recall without the Secretary's written consent

Query this from an agent

The graph holds this control, the 0 it maps to, and the evidence behind each claim, over MCP and REST.

MCP endpoint All Australia Therapeutic Goods Act 1989 controls